The ZNF217 biomarker predicts low-and high-risk oncotype DX® recurrence score in ER-positive invasive breast cancers

Pascale A. Cohen, Olivier Loudig, Christina Liu, Joseph Albanese, Susan Fineberg

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The ZNF217 biomarker predicts low-and high-risk oncotype DX® recurrence score in ER-positive invasive breast cancers'. Together they form a unique fingerprint.